학술논문 – 부산대학교 도서관

학술논문

replay검색결과 돌아가기

search검색화면

91P Immune-mediated adverse event (imAE) incidence, timing and association with efficacy in the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in advanced biliary tract cancer (BTC).

Document Type

Article

Author

Antonuzzo, L.; Takahashi, H.; Park, J.O.; Sookprasert, A.; Gillmore, R.; Yang, S-S.; Cundom, J.E.; Petrova, M.; Vaccaro, G.M.; Holmblad, M.; Xiong, J.; Heider, K.; Rokutanda, N.; Oh, D-Y.

Source

Annals of Oncology. Nov2022 Suppl 9, Vol. 33, pS1470-S1470. 1p.

Subject

*CISPLATIN
*GEMCITABINE
*PLACEBOS
BILIARY tract cancer

Language

ISSN

0923-7534

Online Access

Full Text (ScienceDirect 종량제) Full Text (ScienceDirect O/A) Open Access (EBSCO) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일